Paul V. Maier - Jun 9, 2022 Form 4 Insider Report for International Stem Cell CORP (ISCO)

Role
Director
Signature
/s/ Russell Kern, Attorney-in-Fact
Stock symbol
ISCO
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4
Date filed
6/10/2022, 05:01 PM
Previous filing
Feb 28, 2022
Next filing
Jan 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ISCO Stock Option (Right to Buy) Award $0 +139K $0.00 139K Jun 9, 2022 Common Stock 139K $0.47 Direct F1
transaction ISCO Stock Option (Right to Buy) Award $0 +30K $0.00 30K Jun 9, 2022 Common Stock 30K $0.47 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option granted as part of compensation for non-employee directors. Options vest in four equal quarterly increments, beginning 9/09/2022.
F2 Stock option granted as part of compensation for non-employee directors. Options vest fully at the earlier of (i) 06/09/2023 or (ii) the date of the 2023 Annual Meeting of Stockholders.

Remarks:

EX-24 attached